News articles about Humana (NYSE:HUM) have trended somewhat positive on Wednesday, Accern Sentiment Analysis reports. The research firm rates the sentiment of press coverage by monitoring more than twenty million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Humana earned a news sentiment score of 0.16 on Accern’s scale. Accern also gave media coverage about the insurance provider an impact score of 46.5352135301592 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.
These are some of the news headlines that may have effected Accern Sentiment’s scoring:
- Humana expands $0 Premium Medicare Advantage offering for Will County residents (theherald-news.com)
- Humana appoints permanent leader for its foundation (finance.yahoo.com)
- Humana Expands Medicare Advantage Offerings in New Hampshire (finance.yahoo.com)
- Humana Inc. (HUM) Stock Rating Lowered by Zacks Investment Research (americanbankingnews.com)
- $13.29 Billion in Sales Expected for Humana Inc. (HUM) This Quarter (americanbankingnews.com)
Shares of Humana (HUM) opened at 240.43 on Wednesday. The firm has a market capitalization of $34.75 billion, a PE ratio of 19.78 and a beta of 0.86. Humana has a 1-year low of $165.03 and a 1-year high of $259.76. The firm’s 50 day moving average is $247.41 and its 200 day moving average is $235.83.
Humana (NYSE:HUM) last issued its quarterly earnings results on Wednesday, August 2nd. The insurance provider reported $3.49 earnings per share for the quarter, topping the Zacks’ consensus estimate of $3.08 by $0.41. The firm had revenue of $13.53 billion for the quarter, compared to analysts’ expectations of $13.61 billion. Humana had a return on equity of 15.85% and a net margin of 3.37%. During the same quarter last year, the business posted $2.30 EPS. Analysts anticipate that Humana will post $11.56 EPS for the current fiscal year.
The firm also recently announced a dividend, which was paid on Monday, October 16th. Shareholders of record on Friday, September 29th were paid a dividend of $0.40 per share. The ex-dividend date of this dividend was Thursday, September 28th. Humana’s dividend payout ratio (DPR) is presently 13.06%.
A number of research firms have recently weighed in on HUM. ValuEngine raised shares of Humana from a “hold” rating to a “buy” rating in a research note on Friday, September 1st. UBS AG reaffirmed a “neutral” rating and set a $250.00 price target (up from $237.00) on shares of Humana in a research note on Wednesday, August 9th. BidaskClub raised shares of Humana from a “sell” rating to a “hold” rating in a research note on Thursday, August 10th. Cantor Fitzgerald reaffirmed a “neutral” rating and set a $223.00 price target (up from $200.00) on shares of Humana in a research note on Thursday, August 3rd. Finally, Morgan Stanley upped their price target on shares of Humana from $269.00 to $276.00 and gave the stock an “overweight” rating in a research note on Thursday, August 17th. Twelve analysts have rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. The stock presently has an average rating of “Buy” and a consensus price target of $253.90.
WARNING: This article was first posted by The Ledger Gazette and is owned by of The Ledger Gazette. If you are reading this article on another publication, it was stolen and reposted in violation of US & international copyright and trademark laws. The original version of this article can be accessed at https://ledgergazette.com/2017/10/18/somewhat-positive-news-coverage-somewhat-unlikely-to-affect-humana-hum-share-price.html.
In related news, insider Elizabeth D. Bierbower sold 9,786 shares of the business’s stock in a transaction that occurred on Friday, September 1st. The stock was sold at an average price of $259.00, for a total value of $2,534,574.00. Following the completion of the sale, the insider now owns 18,042 shares of the company’s stock, valued at approximately $4,672,878. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, CEO Bruce D. Broussard sold 12,000 shares of the business’s stock in a transaction that occurred on Friday, August 11th. The shares were sold at an average price of $251.88, for a total value of $3,022,560.00. Following the completion of the sale, the chief executive officer now directly owns 80,086 shares of the company’s stock, valued at approximately $20,172,061.68. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 55,595 shares of company stock worth $14,133,706. Company insiders own 0.80% of the company’s stock.
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
Receive News & Ratings for Humana Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc. and related companies with MarketBeat.com's FREE daily email newsletter.